Leukemia, Lymphocytic, Chronic

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Intermittent Fasting and CLL/SLL

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL

Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy

MSC and HSC Coinfusion in Mismatched Minitransplants

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Stem Cell Transplant for Hematological Malignancy

Post Transplant Donor Lymphocyte Infusion

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach

Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)

Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

Clofarabine in Chronic Lymphocytic Leukemia

A Safety Study in Patients With Chronic Lymphocytic Leukemia

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)